Cosmos Health Inc. (COSM)
(Delayed Data from NSDQ)
$0.66 USD
-0.02 (-2.28%)
Updated Jun 14, 2024 03:51 PM ET
After-Market: $0.65 -0.01 (-1.50%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Income Statements
Fiscal Year end for Cosmos Health Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 50 | 56 | 55 | 40 |
Cost Of Goods | NA | 44 | 48 | 47 | 36 |
Gross Profit | NA | 6 | 8 | 8 | 4 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 13 | 13 | 5 | 4 |
Income After Depreciation & Amortization | 0 | -7 | -5 | 3 | 0 |
Non-Operating Income | NA | -2 | 0 | 1 | -1 |
Interest Expense | NA | 4 | 4 | 3 | 2 |
Pretax Income | NA | -13 | -8 | 1 | -3 |
Income Taxes | NA | 1 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -14 | -8 | 1 | -3 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -14 | -8 | 1 | -3 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -6 | -3 | 3 | 0 |
Depreciation & Amortization (Cash Flow) | NA | 2 | 1 | 0 | 1 |
Income After Depreciation & Amortization | 0 | -7 | -5 | 3 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 1.93 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | -33.22 | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | -33.16 | -23.75 | 1.50 | -6.25 |
Fiscal Year end for Cosmos Health Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | 12.82 | 12.36 | 12.35 |
Cost Of Goods | NA | NA | 11.61 | 11.42 | 11.39 |
Gross Profit | NA | NA | 1.21 | 0.95 | 0.96 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 4.23 | 3.53 | 3.61 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | -3.02 | -2.58 | -2.65 |
Non-Operating Income | NA | NA | -0.25 | 1.93 | 2.30 |
Interest Expense | NA | NA | 0.15 | 0.24 | 0.13 |
Pretax Income | NA | NA | -3.42 | -0.89 | -0.49 |
Income Taxes | NA | NA | -0.07 | 0.09 | -0.03 |
Minority Interest | NA | NA | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | NA | -3.35 | -0.98 | -0.46 |
Extras & Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | -3.35 | -0.98 | -0.46 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 12.59 | 10.82 | 10.62 |
Diluted EPS Before Non-Recurring Items | NA | NA | -0.09 | 0.02 | -0.04 |
Diluted Net EPS (GAAP) | NA | NA | -0.27 | -0.09 | -0.04 |